Saturday 17 October 2026 Export ETON’s income statement to Excel — free account

Eton Pharmaceuticals, Inc.

ETON Healthcare Drug Manufacturers Specialty & Generic

Eton Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $80.0 million, up 104.9% from fiscal 2024. In the quarter to June 2026, revenue grew 98.6%, EPS grew 520.0%, free cash flow fell 8.78% and total debt fell 7.54%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

50.40 0.93 −1.81%

Follow ETON

Alert me

Market cap: $1.5B
P/E: 107×
Fwd P/E: 40.3×
Dividend yield: —
F-score: 5/9
Altman Z: 3.55
Beneish M: −2.24
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	6	5	5	4	+8 more TTM periods Free account
ROE Full definition →	35.97%	(5.36%)	(18.19%)	(34.17%)
ROA Full definition →	11.67%	(1.62%)	(5.47%)	(9.52%)
ROIC Full definition →	21.39%	3.06%	(1.71%)	(10.23%)
Return on Tangible Assets Full definition →	53.25%	(15.63%)	(20.52%)	(23.77%)
Average Days of Receivables Full definition →	86.02	56.29	53.67	67.91
Free Cash Flow per Share Full definition →	(0.30)	(0.28)	0.38	0.78
Free Cash Flow Full definition →	(8.39)	(7.70)	10.18	21.01
Capital Expenditures Full definition →	(23.52)	(23.54)	(0.34)	(0.30)
Other line items
Cash ROIC Full definition →	(8.28%)	(9.50%)	12.32%	23.19%
Accounts Receivable Turnover Full definition →	5.37	5.83	9.34	7.53
Accounts Payable Turnover Full definition →	3.35	4.28	4.91	4.04
Inventory Turnover Full definition →	2.62	2.80	2.43	3.64
Average Days of Payables Full definition →	118.17	125.18	107.67	152.18
Days of Inventory on Hand Full definition →	83.21	134.29	151.25	179.89
Tax Rate Full definition →	0.00	(0.01)	0.01	0.03
Research and Development Expense of Revenue Full definition →	5.45%	9.75%	9.71%	7.27%
Selling, General and Administrative Expense of Revenue Full definition →	36.97%	42.67%	44.80%	47.90%
Share Based Compensation of Revenue Full definition →	4.93%	6.71%	6.89%	7.35%
Interest Coverage Full definition →	4.59	0.58	—	(1.00)
Operating CF/Net income Full definition →	1.19	(10.74)	(2.29)	(3.19)
Depreciation/Fixed assets Full definition →	14.70	12.59	14.54	16.81
Capex/Depreciation Full definition →	(4.55)	(5.03)	(0.07)	(0.06)
Revenue per Share Full definition →	3.82	3.19	2.97	2.61
Operating CF per Share Full definition →	0.55	0.58	0.39	0.79
Capex per Share Full definition →	(0.85)	(0.86)	(0.01)	(0.01)
Capex to Sales Full definition →	0.22	0.27	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly